1-4 of 4
Pawel Kalinski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs

Available to Purchase
Bowen Dong, Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M. Bonura, Cindy Sander, Henry Withers, Mark D. Long, Colin Chavel, Scott H. Olejniczak, Hans Minderman, John M. Kirkwood, Robert P. Edwards, Walter J. Storkus, Pedro Romero, Pawel Kalinski
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (10): 1421–1437.
https://doi.org/10.1158/2326-6066.CIR-24-0061
Published: 01 October 2024
View articletitled, NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
Open the PDF for NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs in another window
Includes: Supplementary data
Journal Articles

Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine

Open Access
Amrita Basu, Gabriella K. Albert, Sabrina Awshah, Jashodeep Datta, Krithika N. Kodumudi, Corey Gallen, Amber Beyer, Keiran S.M. Smalley, Paulo C. Rodriguez, Derek R. Duckett, Peter A. Forsyth, Aixa Soyano, Gary K. Koski, Ricardo Lima Barros Costa, Heather Han, Hatem Soliman, Marie Catherine Lee, Pawel Kalinski, Brian J. Czerniecki
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (1): 108–125.
https://doi.org/10.1158/2326-6066.CIR-21-0454
Published: 01 January 2022
View articletitled, Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine
Open the PDF for Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine in another window
Includes: Supplementary data
Journal Articles

Abstract B203: Chemokine modulation to enhance the effectiveness of pembrolizumab in patients with metastatic triple-negative breast cancer

Free
Yara Abdou, Pawel Kalinski, Mateusz Opyrchal
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): B203.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-B203
Published: 01 February 2019
View articletitled, Abstract B203: Chemokine modulation to enhance the effectiveness of pembrolizumab in patients with metastatic triple-negative breast cancer
Journal Articles

Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment

Free
Jeffrey L. Wong, Nataša Obermajer, Kunle Odunsi, Robert P. Edwards, Pawel Kalinski
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (4): 303–311.
https://doi.org/10.1158/2326-6066.CIR-15-0157
Published: 31 March 2016
View articletitled, Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment
Open the PDF for Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment in another window
Includes: Supplementary data